- Data Generated to Date Support Potential for Aclaris' ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced the availability of a new publication describing the unique properties of Aclaris Therapeutics' ATI-2138, a novel investigational covalent inhibitor of interleukin-2-inducible T cell kinase (ITK) and Janus kinase 3 (JAK3) in development for the treatment of autoimmune and inflammatory diseases.

CHICAGO--(BUSINESS WIRE)--Exelon Corporation (Nasdaq: EXC) today reported its financial results for the fourth quarter and full year 2024. "I am pleased to announce Exelon has delivered against our financial goals for the third straight year since becoming a transmission and delivery-only company, and we delivered top quartile performance across all our local energy companies, with ComEd and Pepco Holdings in the top decile," said Exelon President and Chief Executive Officer Calvin Butler. "Our.

Restaurant Brands International reported quarterly adjusted earnings per share of 81 cents and revenue of $2.3 billion. Burger King's and Popeyes' U.S. restaurants outperformed Wall Street's expectations.

Alphabet's Google Cloud grew 30% YoY in Q4'24, with operating margins rising to 17.51%, driven by strong AI and developer adoption. Management plans to deploy $75B in eFY25 to boost compute capacity, supporting further growth in Google Cloud and AI initiatives. Despite capacity constraints, Alphabet's AI tools like Gemini 2.0 and Vertex AI are seeing significant adoption, enhancing internal efficiencies with AI agents automating processes.

Biogen forecast 2025 profit below Wall Street expectations on Wednesday, hurt by a strong dollar and fierce competition for its drugs to treat multiple sclerosis.

TE Connectivity is buying electrical products maker Richards Manufacturing for $2.3 billion.

RIG is expected to report higher revenues from the year-ago period's level. Despite this revenue growth, it is expected to have faced increased costs and expenses.

MRC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 12, 2025.

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today it has been awarded a study contract from the European Space Agency (ESA) to develop the preliminary spacecraft design for an upcoming astrophysics mission that will image faint galaxies in the nearby universe and provide insight into the nature of dark matter. Redwire's wholly owned Belgian subsidiary, Redwire Space NV, has been awarded o.

Fourth Quarter and Full Year 2024 Results All amounts expressed in US dollars TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) delivered a strong performance in Q4, increasing gold production by 15% and copper production by 33% over Q3 to meet its annual guidance for the year. Additionally, gold cost of sales1 and total cash costs2 for the quarter were reduced by 3% and 5%, respectively.

Fourth Quarter 2024 Financial Results and Highlights

GRAND CAYMAN, Cayman Islands, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Patria (Nasdaq:PAX) reported today its unaudited results for the fourth quarter and full year ended December 31, 2024. The full detailed presentation of Patria's fourth quarter and full year 2024 results can be accessed on the Shareholders section of Patria's website at https://ir.patria.com/.

- Additional patent granted for photocurable dermal filler- Update on AbbVie dermal filler program and achievement of contingent payment- Plan for cost reductions in place to extend cash runway REHOVOT, Israel , Feb. 12, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today provided a corporate update. Photocurable Dermal Filler Program: Additional Patent Granted CollPlant today announced it has been granted U.S. Patent No.

SHANGHAI , Feb. 12, 2025 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced it plans to release its unaudited financial results for fourth quarter and fiscal year of 2024 ended December 31, 2024 before U.S. markets open on Thursday, February 27, 2025. The Company has scheduled a conference call to discuss the results at 8:00 AM U.S. Eastern Time on February 27, 2025 (9:00 PM Beijing / Hong Kong time on the same day).

Shares of Berkshire Hathaway (BRK.A 0.50%) (BRK.B 0.52%) are trading near their all-time highs, just like the S&P 500 index (^GSPC 0.03%). For that reason, Warren Buffett's company may not be of much interest if you are a diehard value investor committed to finding cheap stocks.

Archer Aviation (ACHR -8.92%) is nearing approval to begin flying an innovative vertical take off and landing aircraft that could disrupt air travel as we know it. Not only is the company working with the military, you may be able to ride in an aircraft with an air taxi service in the U.S. and abroad.

DUBLIN, Ireland , Feb. 12, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its fourth quarter and full year 2024 financial results and provide a business update after market close on Wednesday, February 26, 2025. An accompanying conference call and simultaneous webcast will be hosted at 5:00 pm EST (2:00 pm PST/10:00 pm GMT) that day.

Fiserv's all-cash offer provides highly attractive, certain, and immediate value to Payfare shareholders Payfare's Board of Directors unanimously recommends shareholders vote "FOR" the proposed transaction with Fiserv Leading proxy advisors ISS and Glass Lewis have also recommended shareholders vote "FOR" the proposed transaction with Fiserv Payfare sets the record straight on inaccurate statements and omissions by Kingsferry TORONTO , Feb. 12, 2025 /PRNewswire/ - Payfare Inc. ("Payfare" or the "Company") (TSX: PAY) (OTCQX: PYFRF) today reiterated the unanimous recommendation of its Board of Directors (the "Board") that shareholders vote "FOR" the proposed arrangement agreement (the "Arrangement") with Fiserv, Inc. ("Fiserv") …

Highlights Fourth Quarter 2024 Sales of $873 million exceeded high-end of guidance range, grew 6% as reported and 8% in constant currency Instruments grew 8% and recurring revenue grew 9% in constant currency, as growth accelerated across all three reported regions Pharma grew 10% in constant currency, reflecting stronger-than-expected year-end spending dynamics and broad-based growth across the Americas, Europe, and Asia GAAP EPS of $3.88; non-GAAP EPS of $4.10 grew 13% as strong operational performance and better-than-expected sales volume offset foreign exchange headwinds Full-Year 2024 Sales exceeded guidance at $2,958 million, flat as reported and in organic constant currency GAAP …

This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated October 3, 2024 to its short form base shelf prospectus dated September 11, 2024. San Antonio, Texas--(Newsfile Corp. - February 12, 2025) - HIVE Digital Technologies Ltd.